Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers March 23, 2019
Pharmacy Choice - Pharmaceutical News - Department of Health Issues Request to Choose Partner for Hepatitis C Drug Payment Model - March 23, 2019

Pharmacy News Article

 1/11/19 - Department of Health Issues Request to Choose Partner for Hepatitis C Drug Payment Model

BATON ROUGE, Louisiana, Jan. 10 The Louisiana Department of Health issued the following news release:

Today, the Louisiana Department of Health released a solicitation for offers (SFO) to identify a pharmaceutical partner to negotiate unrestricted access to curative treatment for hepatitis C for Medicaid and incarcerated patients in Louisiana.

The SFO will allow the Department to develop an arrangement through a public/private partnership with a hepatitis C drug manufacturer that will bring the goal of ending the hepatitis C epidemic within reach for the people of the state of Louisiana.

In the United States, hepatitis C kills more people than all other infectious diseases combined. At least 39,000 people in Louisiana's Medicaid program and prison system suffer from hepatitis C infection. The opioid crisis has only increased the number of infections. Because of the high cost of the drug, less than three percent of Medicaid patients who have hepatitis C were treated last year.

"The state cannot afford to eliminate hepatitis C in patients at current drugs prices. Our innovative model will allow us to dramatically expand access to the drug and eventually eliminate hepatitis C as a public health problem," said Governor John Bel Edwards. "Secretary Gee and other leaders within the Department of Health have been thinking outside the box, collecting the best ideas from policymakers, patients, payors and governors from other states to ensure we are pursuing a model that is both realistic and one that can be successful."

In August of 2018, the Department of Health issued a request for information seeking comments on a subscription payment model. The comments received, along with feedback from state leaders and policy experts, were strongly considered and included in the state's formal SFO.

"Our Department is pursuing a subscription model for hepatitis C treatment that will give us the opportunity to solve a major public health challenge and put a cure within reach for our most vulnerable populations while keeping health care costs stable," said Dr. Rebekah Gee, secretary, Louisiana Department of Health.

The Department of Health's goal is to treat over 10,000 Medicaid-enrolled and incarcerated individuals by the end of 2020 through the subscription model, with the ultimate goal of eliminating this disease. The Department expects the partnership to begin on July 1, 2019. The result of this partnership will allow Louisiana to have unlimited access to highly effective direct-acting antiviral treatment(s) for five years.

"This subscription model effectively caps the State's spending on expensive hepatitis C drugs and creates an incentive to treat as many infected people as possible. For the drug manufacturer, this model would guarantee fixed revenue for a contracted period of time and allow the manufacturer to expand their product reach into populations that otherwise would not have received treatment," added Edwards.

In order to cure as many infected individuals as possible across the state, the Department of Health will implement a number of additional strategies to complement the increased access to treatment enabled by the subscription model.

"This model helps the Medicaid population and the state's prison population. We have made a commitment to help offenders successfully return to their communities and part of doing that is to ensure they have access to health care coverage and are free from illness such as hepatitis C," said Jimmy LeBlanc, secretary, Department of Corrections.

Click here for the complete solicitation of offers (

© 2019 Targeted News Service

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Last Chance
Mar 24: A Look Inside the Top 200 Drugs
Mar 25: Medication Use During Pregnancy & Lactation
Mar 26: Nutrigenomics - Nutritional Influences on the Genome
Mar 27: ADHD in Children & Adults: Etiology, Pathology, Pharmacotherapy
Mar 28: Alternatives and Complements to Prescription Pain Management
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.

Websites »
Copyright © 2019 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement